Patient Phenotypes and SGLT-2 Inhibition in Type 2 Diabetes-Reference-Cited by-同舟云学术

Patient Phenotypes and SGLT-2 Inhibition in Type 2 Diabetes

Published:2021-08 Issue:8 Volume:9 Page:568-577
ISSN:2213-1779
Container-title:JACC: Heart Failure
language:en
Short-container-title:JACC: Heart Failure

Author:

Sharma Abhinav,Ofstad Anne Pernille,Ahmad Tariq,Zinman Bernard,Zwiener Isabella,Fitchett David,Wanner Christoph,George Jyothis T.,Hantel Stefan,Desai Nihar,Mentz Robert J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference44 articles.

1. Impact of diabetes mellitus on hospitalization for heart failure, cardiovascular events, and death: outcomes at 4 years from the Reduction of Atherothrombosis for Continued Health (REACH) registry;Cavender;Circulation.,2015

2. Causes of death in a contemporary cohort of patients with type 2 diabetes and atherosclerotic cardiovascular disease: insights from the TECOS trial;Sharma;Diabetes Care.,2017

3. Trends in noncardiovascular comorbidities among patients hospitalized for heart failure: insights from the Get With The Guidelines-Heart Failure registry;Sharma;Circ Heart Fail.,2018

4. Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored;McMurray;Lancet Diabetes Endocrinol.,2014

5. Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response;Kao;Eur J Heart Fail.,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium-Glucose Cotransporter-2 Inhibitors and Cardiovascular Protection Among Patients With Type 2 Diabetes Mellitus: A Systematic Review;Journal of Diabetes Research;2024-05-11

2. SGLT2 inhibitor improves the prognosis of patients with coronary heart disease and prevents in-stent restenosis;Frontiers in Cardiovascular Medicine;2024-01-11

3. Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review;Communications Medicine;2023-10-05

4. Dapagliflozin reduces risk of heart failure rehospitalization in diabetic acute myocardial infarction patients: a propensity score-matched analysis;European Journal of Clinical Pharmacology;2023-04-26

5. Precision medicine in type 2 diabetes: A systematic review of treatment effect heterogeneity for GLP1-receptor agonists and SGLT2-inhibitors;2023-04-22